Usefulness of EMA, GLUT-1, and XIAP for the Cytologic Diagnosis of Malignant Mesothelioma in Body Cavity Fluids
Open Access
- 1 April 2009
- journal article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 131 (4), 516-523
- https://doi.org/10.1309/ajcpwfw7o1fvflkt
Abstract
We compared the effectiveness of epithelial membrane antigen (EMA) with 2 newly described markers, X-linked inhibitor of apoptosis protein (XIAP) and an isoform of glucose transporter (GLUT-1), in the distinction between malignant mesothelioma (MM) and benign effusion (BE) in body cavity fluids. Immunohistochemical studies were performed on cell block sections from 35 cases of histologically confirmed MM and 38 BEs, using antibodies to EMA, XIAP, GLUT-1 (GLUT-1m, monoclonal; GLUT-1p, polyclonal). Results were graded based on the percentage of cells staining: negative (0%), 1+ (<25%), 2+ (25%–49%), 3+ (50%–74%), and 4+ (75%–100%). The performance of each marker was compared using receiver operating characteristic curve analysis. EMA demonstrated the best accuracy, with an area under the curve of 0.91 as compared with XIAP (0.67), GLUT-1m (0.74), and GLUT-1p (0.80). Based on these findings, EMA is a better marker than XIAP or GLUT-1 for the diagnosis of MM.Keywords
This publication has 39 references indexed in Scilit:
- Immunohistochemical Detection of XIAP in Mesothelium and Mesothelial LesionsAmerican Journal of Clinical Pathology, 2007
- Expression of inhibitor-of-apoptosis protein family members in malignant mesotheliomaHuman Pathology, 2007
- Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesotheliomaLaboratory Investigation, 2007
- Sensitivity and specificity of immunohistochemical antibodies used to distinguish between benign and malignant pleural disease: a systematic review of published reportsHistopathology, 2006
- Immunocytochemical detection of XIAP in body cavity effusions and washesLaboratory Investigation, 2005
- Diagnostic value of GLUT‐1 immunoreactivity to distinguish benign from malignant cystic squamous lesions of the head and neck in fine‐needle aspiration biopsy materialDiagnostic Cytopathology, 2004
- The use of histological and immunohistochemical markers to distinguish pleural malignant mesothelioma andin situ mesothelioma from reactive mesothelial hyperplasia and reactive pleural fibrosisThe Journal of Pathology, 1999
- Immunoreactivity for bcl-2 protein in malignant mesothelioma and non-neoplastic mesotheliumVirchows Archiv, 1994
- Cytopathology of malignant mesothelioma: A study of its patterns and histological basesDiagnostic Cytopathology, 1993
- Immunoreactivity for the β chain of the platelet‐derived growth factor receptor in malignant mesothelioma and non‐neoplastic mesotheliumThe Journal of Pathology, 1992